Subsense, Inc. raised $17M in seed funding led by Golden Falcon Capital to develop a non-surgical brain-computer interface using nanoparticle-based technologies.

Feb 18, 2025•10 months ago

Amount Raised

$17 Million

Round Type

seed

Marina Del ReyMedical DeviceMedicalBiotechnologyHealth Care

Investors

Golden Falcon Capital

Description

Subsense, Inc. has emerged from stealth with $17M in seed funding to accelerate the development of its innovative brain-computer interface. The funding round was led by Golden Falcon Capital, aiming to enhance neural connectivity through non-invasive methods.

Company Information

Company

Subsense

Location

Marina Del Rey, California, United States

About

Subsense, Inc. is a neurotechnology company developing the first non-surgical, nanoparticle-based bidirectional brain-computer interface. Subsense is partnered with leading global neurological research institutions. The company is venture-backed with its global headquarters in Palo Alto, California. It is co-founded by neurotech entrepreneur Tetiana Aleksandrova and serial entrepreneur Artem Sokolov, who has been an early investor in companies that include: Asana, SoFi, Coursera, Lemonade, Digital Ocean among many others.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends